☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Pfizer Reports P-III (MATISSE) Trial Results of RSVpreF for the Treatment of Respiratory Syncytial Virus
November 1, 2022
Memo Therapeutics AG Entered into a Research and Development Collaboration Agreement with Ono to Discover Antibodies Against Immun...
November 1, 2022
Dyne Therapeutics’ DYNE-251 Receives the US FDA’s Fast Track Designation for the Treatment of Duchenne Muscular Dystrophy
November 1, 2022
Eucure Biopharma Subsidiary of Biocytogen Collaborated with ISU ABXIS to Develop Tri-Specific Antibodies Using YH003 Antibody Sequ...
November 1, 2022
Antengene Receives the US FDA’s IND Clearance of ATG-017 to Initiate P-I (ERASER) Trial for Advanced Solid Tumors
November 1, 2022
Ascendis Pharma Reports the US FDA’s Acceptance of NDA for Priority Review of TransCon PTH to Treat Hypoparathyroidism in Adult Pa...
November 1, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions